Chemoinformaics analysis of Ethyl anthranilate
Molecular Weight | 165.192 | nRot | 2 |
Heavy Atom Molecular Weight | 154.104 | nRig | 7 |
Exact Molecular Weight | 165.079 | nRing | 1 |
Solubility: LogS | -2.341 | nHRing | 0 |
Solubility: LogP | 2.344 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 1 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 23 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 12 | No. of Aromatic Carbocycles | 1 |
nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 11 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 9 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 1 | No. of Arom Atom | 6 |
No. of Oxygen atom | 2 | No. of Arom Bond | 6 |
nHA | 3 | APOL | 25.0687 |
nHD | 1 | BPOL | 13.0693 |
QED | 0.533 |
Synth | 1.517 |
Natural Product Likeliness | -0.451 |
NR-PPAR-gamma | 0.005 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0.001 |
Pgp-sub | 0.202 |
HIA | 0.003 |
CACO-2 | -4.383 |
MDCK | 0.0000554 |
BBB | 0.979 |
PPB | 0.741323 |
VDSS | 1.477 |
FU | 0.301035 |
CYP1A2-inh | 0.973 |
CYP1A2-sub | 0.55 |
CYP2c19-inh | 0.814 |
CYP2c19-sub | 0.511 |
CYP2c9-inh | 0.381 |
CYP2c9-sub | 0.261 |
CYP2d6-inh | 0.209 |
CYP2d6-sub | 0.653 |
CYP3a4-inh | 0.225 |
CYP3a4-sub | 0.184 |
CL | 9.354 |
T12 | 0.484 |
hERG | 0.084 |
Ames | 0.028 |
ROA | 0.033 |
SkinSen | 0.377 |
Carcinogencity | 0.155 |
EI | 0.992 |
Respiratory | 0.829 |
NR-Aromatase | 0.022 |
Antiviral | No |
Prediction | 0.877342 |